文献速递腹部CT

胰腺坏死体积预测急性坏死性胰腺炎再入院与再干预

Pancreatic necrosis volume for predicting readmission and reintervention in acute necrotizing pancreatitis.
PubMed 文献 · Eur J Radiol · 2022-06-22

回顾性队列纳入167例坏死性胰腺炎患者,出院前一周行增强CT手动测量胰腺坏死体积(PNV)。PNV≥620 cm³与再入院(adjOR 3.08)及再干预(adjOR 5.11)独立相关。PNV有助于量化胰腺坏死并预测再入院与再干预。

要点

  • 出院前增强CT测量的胰腺坏死体积(PNV)与再入院和再干预独立相关。
  • PNV≥620 cm³是再入院(adjOR 3.08)和再干预(adjOR 5.11)的独立危险因素。
  • 改良CTSI评分≥7分同样与再入院(adjOR 6.36)和再干预(adjOR 4.23)独立相关。

核心结论

  • PNV是量化胰腺坏死的有用工具,与再入院和再干预强相关;需要更大样本的前瞻性研究来证实这些发现。

研究设计与样本

  • 回顾性队列研究,纳入167例坏死性胰腺炎患者,出院前一周行增强CT检查,基于后处理工作站软件手动计算PNV,采用多变量逻辑回归分析确定再入院和再干预的独立危险因素。

关键影像表现/征象

  • 全部患者PNV中位数为376.6 cm³(四分位距129.3-820.5 cm³)。
  • 需要再入院或再干预的患者PNV显著更高。

诊断标准与关键数值

  • PNV≥620 cm³预测再入院:adjOR 3.08(95%CI 1.47-6.43,P=0.003)。
  • PNV≥620 cm³预测再干预:adjOR 5.11(95%CI 2.19-11.95,P<0.001)。
  • 改良CTSI评分≥7分预测再入院:adjOR 6.36(95%CI 2.05-10.70,P=0.001)。
  • 改良CTSI评分≥7分预测再干预:adjOR 4.23(95%CI 1.46-12.27,P=0.008)。
  • 出院时留置支架或引流管预测再干预:adjOR 2.94(95%CI 1.27-6.77,P=0.011)。

临床应用与阅片要点

  • 出院前增强CT可手动测量PNV,用于量化胰腺坏死范围并评估再入院与再干预风险。
  • PNV≥620 cm³和改良CTSI评分≥7分提示再入院及再干预风险升高。
  • 胰腺实质坏死与再干预独立相关(adjOR 3.37,95%CI 1.42-7.96,P=0.006)。

局限性

  • 原文结论指出需要更大样本的前瞻性研究来证实这些发现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To determine the correlation between the pancreatic necrosis volume (PNV) and readmission as well as reintervention.

METHOD: This was a retrospective cohort study that included necrotizing pancreatitis (NP) patients who were examined with contrast-enhanced computed tomography (CT) one week before discharge. The PNV was calculated manually based on the postprocessing workstation software. Multivariate logistic regression analysis was employed to determine the independent risk factors for readmission and reintervention.

RESULTS: A total of 167 NP patients were included. Among them, 94 (56.3%) patients were readmitted after discharge, and 55 (32.9%) patients needed further invasive intervention. The median PNV of all patients was 376.6 (interquartile range (IQR), 129.3-820.5) cm3, and the PNV was significantly higher in patients needing readmission or reintervention. Multivariate analysis showed that PNV ≥ 620 cm3 (adjusted odds ratio (adjOR), 3.08; 95% confidence interval (CI), 1.47-6.43; P = 0.003) and modified computed tomography severity index (CTSI) score ≥ 7 points (adjOR, 6.36; 95% CI, 2.05-10.70; P = 0.001) were independently associated with readmission. Stent or drainage tube placement at discharge (adjOR, 2.94; 95% CI, 1.27-6.77; P = 0.011), PNV ≥ 620 cm3 (adjOR, 5.11; 95% CI, 2.19-11.95; P < 0.001), pancreatic parenchymal necrosis (adjOR, 3.37; 95% CI, 1.42-7.96; P = 0.006), and modified CTSI score ≥ 7 points (adjOR, 4.23; 95% CI, 1.46-12.27; P = 0.008) were independent risk factors for reintervention.

CONCLUSIONS: The PNV is a useful tool for quantifying pancreatic necrosis and is strongly associated with readmission and reintervention. Additional prospective studies with larger sample sizes are needed to confirm these findings.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Liao, Ding, Xu, et al. Pancreatic necrosis volume for predicting readmission and reintervention in acute necrotizing pancreatitis. Eur J Radiol. 2022. PMID: 35878514. doi:10.1016/j.ejrad.2022.110419

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。